PubAg

Main content area

Isoflurane with morphine is a suitable anaesthetic regimen for embryo transfer in the production of transgenic rats

Author:
Smith, Jennifer C., Corbin, Timothy J., McCabe, James G., Bolon, Brad
Source:
Laboratory animals 2004 v.38 no.1 pp. 38-43
ISSN:
1758-1117
Subject:
adults, depth of anesthesia, eggs, embryo (animal), embryo transfer, females, intramuscular injection, isoflurane, ketamine, laboratory animals, laparotomy, morphine, oxygen, pregnancy rate, prospective studies, pups, rats, transgenic animals, uterus, xylazine
Abstract:
During our initial attempts to produce transgenic rats, we found that an anaesthetic combination typically used for embryo transfer (intramuscular injection of ketamine [90 mg/kg] with xylazine [10 mg/kg]) yielded extensive variation in both the depth and length of anaesthesia. In the present prospective study, we compared the reproductive outcomes afforded by using either isoflurane (5% for induction, 2% for maintenance, carried in 2 l/min of oxygen) with morphine (5 mg/kg s.c., given immediately after isoflurane induction) or ketamine/xylazine in adult (250–300 g), pseudopregnant Sprague-Dawley rats. Each animal was anaesthetized with either isoflurane/morphine or ketamine/xylazine, after which 30 microinjected eggs were transferred into the left uterine horn. The mean pregnancy rate for isoflurane/morphine (15%) was 50% greater than that achieved with ketamine/xylazine (10%). The mean number of live pups (just over five per litter) was comparable for both regimens. All rats given isoflurane/morphine quickly achieved a surgical depth of anaesthesia and experienced a rapid postoperative recovery (3–5 min). In contrast, 25% of rats injected with ketamine/xylazine did not reach a depth of anaesthesia within 10 min that was sufficient for laparotomy, and all that were anaesthetized successfully required an extended postoperative recovery period (60–90 min). These data show that isoflurane/morphine is well tolerated by microinjected embryos and suggest that its use during embryo transfer may provide a means for both reducing the number of pseudopregnant females used and increasing the speed with which rat transgenic projects are completed.
Agid:
6246640